AKTX
Akari Therapeutics
AKTX
AKTX
8 hedge funds and large institutions have $1.19M invested in Akari Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less funds holding
Funds holding: 16 → 8 (-8)
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Holders
8
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$79K | |
| 2 | +$29.6K | |
| 3 | +$6.15K | |
| 4 |
CPG
Cornerstone Planning Group
Fairfield,
New Jersey
|
+$20 |
Top Sellers
| 1 | -$756K | |
| 2 | -$36.8K | |
| 3 | -$22.9K | |
| 4 |
Millennium Management
New York
|
-$22.8K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
-$22K |